This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Pacira Pharmaceuticals Inc (PCRX)

: Health Care

Company Balance Sheet
Dec 2015 Dec 2014 Dec 2013 Dec 2012
Assets
Cash and Equivalents 56.98M 37.52M 12.52M 10.13M
Receivables 25.86M 22.37M 14.59M 4.35M
Inventories 61.65M 29.26M 15.56M 12.08M
Other Current Assets 0.00 0.00 0.00 0.00
Total Current Assets 252.58M 214.26M 106.75M 60.92M
Property, Plant & Equipment, Gross 115.24M 80.75M 60.76M 50.72M
Accumulated Depreciation & Depletion 24.92M 20.11M 12.58M 11.60M
Property, Plant & Equipment, Net 90.32M 60.63M 48.18M 39.12M
Intangibles 81.00K 403.00K 1.16M 3.21M
Other Non-Current Assets 15.76M 27.02M 3.40M 511.00K
Total Non-Current Assets 137.04M 111.81M 63.07M 51.13M
Liabilities & Shareholder Equity
Total Assets 389.62M 326.07M 169.82M 112.05M
Accounts Payable 8.74M 6.76M 3.07M 2.57M
Short Term Debt 0.00 276.00K 0.00 0.00
Other Current Liabilities 208.00K 139.00K 1.02M 823.00K
Total Current Liabilities 151.68M 140.01M 121.94M 14.16M
Long Term Debt 0.00 0.00 0.00 25.19M
Deferred Income Taxes 0.00 0.00 0.00 0.00
Other Non-Current Liabilities 19.55M 14.92M 6.63M 6.85M
Minority Interest 0.00 0.00 0.00 0.00
Total Non-Current Liabilities 19.55M 14.92M 6.63M 32.04M
Total Liabilities 171.23M 154.93M 128.57M 46.20M
Preferred Stock Equity 0.00 0.00 0.00 0.00
Common Stock Equity 218.39M 171.15M 41.25M 65.86M
Common Par 37.00K 36.00K 34.00K 33.00K
Additional Paid In Capital 526.70M 481.33M 337.64M 298.32M
Cumulative Translation Adjustment 0.00 0.00 0.00 0.00
Retained Earnings -308.29M -310.14M -296.43M -232.52M
Treasury Stock 0.00 0.00 0.00 -2.00K
Other Equity Adjustments -52.00K -80.00K 5.00K 27.00K
Total Capitalization 218.39M 171.15M 41.25M 91.05M
Total Equity 218.39M 171.15M 41.25M 65.86M
Total Liabilities & Stock Equity 389.62M 326.07M 169.82M 112.05M
Total Common Shares Outstanding 36.85M 36.15M 33.64M 32.62M
Preferred Shares 0.00 0.00 0.00 0.00
Treasury Shares 0.00 0.00 0.00 1.06K
Basic Weighted Shares Outstanding 36.54M 35.30M 33.18M 30.33M
Diluted Weighted Shares Outstanding 41.30M 35.30M 33.18M 30.33M
Number of Employees 487 447 308 133
Number of Part-Time Employees 0 0 2 0
PCRX News

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free

PCRX Pacira Pharmaceuticals Inc

Chart of PCRX

Analysts Ratings for PCRX

Rating Current 1-Mo Ago 2-Mo Ago 3-Mo Ago
Strong Buy 7 6 6 7
Moderate Buy 0 0 0 0
Hold 1 1 1 1
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
GET PCRX ANALYST REPORT

PCRX Chatter

Top Rated Stocks Top Rated Funds Top Rated ETFs